ADAPT Pharma Expands Donations of NARCAN
In March, ADAPT Pharma, a subsidiary of Emergent BioSolutions and CSG Associate, announced the expansion of its program offering free NARCAN Nasal Spray – the leading community use naloxone – to U.S. high schools and eligible colleges and universities. NARCAN Nasal Spray 4mg is the only FDA-approved, needle-free formulation of naloxone for the emergency treatment of a known or suspected opioid overdose. As part of this effort, ADAPT Pharma will:
- Expand free NARCAN Nasal Spray availability by eliminating the prior 20,000 cartons cap for eligible colleges and universities
- Double the allocation to high schools from one free carton (two 4mg doses) to two free cartons (four 4mg doses)
- Extend the term of the free NARCAN Nasal Spray offer until it is in every high school and eligible college and university in the United States
ADAPT Pharma seeks to raise public awareness of the potential risks of opioids and the importance of preparedness in case of an opioid emergency. Specifically, ADAPT Pharma will continue its commitment to expand access to naloxone by offering one free box of NARCAN® and educational materials to all 16,568 public libraries and 2,700 YMCAs in the United States.
“According to the Centers for Disease Control and Prevention, in 2016, there were approximately 42,000 deaths in the U.S. due to opioid overdose,” said Doug White, senior vice president and head of Emergent BioSolution’s devices business unit. “The U.S. government has declared the opioid crisis a public health emergency and has identified the availability and distribution of overdose-reversing drugs, such as NARCAN Nasal Spray, as one of the strategies to combat this crisis. We are committed to further expanding awareness and availability of NARCAN Nasal Spray as a convenient, easy-to-administer emergency treatment by leveraging the combination of Adapt Pharma’s efforts with state and local governments, first responders, pharmacies and other channels.”
Associates in Action articles highlight CSG Associates’ philanthropic efforts and public-private partnerships throughout the states.